This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, click the "Reprints" link at the top of any article.
Abbott To Sell $14.7 Bln of Bonds
Deal set to be biggest U.S. fixed-income issue since 2009.
Abbott Laboratories is planning to sell $14.7 billion of bonds in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two.
Through its AbbVie Inc. pharmaceutical unit, Abbott may sell bonds in six parts ranging in size from $500 million to $4 billion, according to a person familiar with the transaction.
Copyright 2016 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.